Crinetics Pharmaceuticals
CRNX
#2695
Rank
โ‚น433.70 B
Marketcap
โ‚น4,677
Share price
-0.51%
Change (1 day)
69.38%
Change (1 year)

Revenue for Crinetics Pharmaceuticals (CRNX)

Revenue in 2024 (TTM): โ‚น86.62 Million

According to Crinetics Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚น88.2 Million. In 2023 the company made a revenue of โ‚น0.33 Billion a decrease over the revenue in the year 2022 that were of โ‚น0.39 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Crinetics Pharmaceuticals from 2017 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น86.62 M-74.07%
2023 โ‚น0.33 B-14.77%
2022 โ‚น0.39 B388.54%
2021 โ‚น80.23 M
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA